• Home
  • Development of Heparin and HS Glycotherapeutics
  • Lab
  • People

Ferniglab Blog

The personal blog of Dave Fernig, thoughts on science and unrelated matters

Feeds:
Posts
Comments
« A Paradox
Work on Week March 16 »

The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding

March 3, 2020 by ferniglab


Thursday last week (Feb 27) Mark was up from Keele and popped his head around my office door – not a surprise, as he is often here to do circular dichroism on various heparin-binding proteins – to announce that Marcelo had managed to make some SARS-CoV-2 S1 receptor binding domain. Mark had asked Hao,  my postdoc, to do some SPR measurements to see if it bound heparin.

Later in the day I went over to the SPR/CD lab to find Courtney, Mark’s PhD student and Mark beavering away on the CD. A quick discussion. Hao had finished some work on our first grade A heparin functionalised SPR surface, so we set about injecting the SARS-CoV-2 surface protein (Spike) S1 Receptor Binding Domain – a one shot experiment, as amounts of protein were limited, so we injected 1 mL at 500 µL/min (I like high flow rates as mixing is way better, though still far from perfect).

Bingo.

Still the control to do, since though confident in the surface’s resistance to non-specific binding, we still needed to be sure. So we collected the effluent fraction with the Receptor Binding Domain and then passed that through the pump (we are still sorting out fluidics etc., instrument only arrived a month ago) onto the reference channel (streptavidin, no heparin). Small drop due to mismatch in refractive index of the receptor binding domain and the running buffer, and then nothing. Back to running buffer and we go to baseline, no binding.

We agreed we should write up the experiments and put them out as a preprint. The work was not done in a vacuum. SARS-1 receptor binding domain binds heparin and its interaction with cellular heparan sulfate looks to be important in viral adhesion and cell entry (as for many viruses) and the corresponding region of the SARS-2 protein is identical. As we note in the preprint, this may provide a route to first line therapy, while we await a vaccine and other therapeutics.

The experiments depended on many other factors, which are worth considering, when we think about how research and innovation actually occur.

Back in the day, I had a suite of IAsys optical biosensors – brilliant instruments, with a vibrostirrer so we had proper mixing and never had issues with mass transport. The company bit the dust sadly, so these became legacy and then were scrapped. As a back up a colleague had a Biacore, but that packed up too. Personally I never liked these, as they are too ‘closed’ and I much prefer instruments that are open, without any ‘black box’ or inaccessible elements. Last year a new colleague, Roy Goodacre, hosted a seminar by Jean-François Masson from Montreal on SPR. So I went along and was taken by the instrument Jean-François had developed – open architecture in terms of fluidics, small, portable (he developed it to measure explosive residues in ground water used by communities near Canadian Army ranges). We had a chat after the seminar, and I contacted the company he has set up to commercialise the instrument. Some months later, when I had the time, I went around the Biochemistry Department with my hat and we put together the cash and bought a P4SPR, delivered end January 2020. I then set out plumbing in fluidics and making biotinylated oleyl ethelene glycol self assembled monolayers on the gold surface, with help from Richard Nichols in our Chemistry department who has a plasma cleaner.

So a group of people happy to work together with no discussion regarding ownership etc. and willing to stump up a few £ to buy a modest, yet powerful piece of kit. This really boils down to trust in your colleagues, be they PhD students or Professors and it is a real pleasure to work at ground level in such an environment. It is also an environment where you can innovate, something that still excites me.

Advertisement

Share this:

  • Twitter
  • Facebook
  • LinkedIn

Like this:

Like Loading...

Related

Posted in Biochemistry, Glycobiology, Science process, Scientific progress, Viruses | Tagged heparan sulphate, heparin, research, SARS-CoV-2, science, Universities | 1 Comment

One Response

  1. on April 29, 2020 at 12:45 pm Heparin inhibits SARS-cov-2 cell infectivity | Ferniglab Blog

    […] to determine if this is actually the case takes time. It is nearly a month since the the team’s initial preprint (now updated with low molecular weight heparins), which was the first demonstration of an […]



Comments are closed.

  • Places of interest

    The one and only PhD comics, the guide to being a graduate and to mentoring.

    Improbable Research and the Ig Nobels

    Retraction Watch provides updates on retractions of articles.

    Office for Research Integrity, their video should be compulsory for all.

    Centre for Alternative Technology

    Lateral Science, has some quite stunning information - well worth a browse.

    Fascinating places that have been closed by lawyers

    Science Fraud, shut down due to legal threats on Jan 3 2013. and Abnormal Science

  • Blogroll

    • WordPress.com
    • WordPress.org
  • Funding agencies

    • Biotechnology and Biological Sciences Research Council
    • Cancer and Polio Research Fund
    • Engineering and Physical Sciences Research Council
    • Liverpool Pancreas NIHR Biomedical Research Unit
    • Medical Research Council
    • North West Cancer Research
  • Seminars

    • Cancer Research UK Centre
  • March 2020
    M T W T F S S
     1
    2345678
    9101112131415
    16171819202122
    23242526272829
    3031  
    « Dec   Apr »
  • Archives

    • November 2022
    • July 2022
    • April 2022
    • March 2022
    • May 2021
    • March 2021
    • August 2020
    • June 2020
    • April 2020
    • March 2020
    • December 2019
    • October 2019
    • July 2019
    • May 2019
    • April 2019
    • January 2019
    • September 2018
    • August 2018
    • May 2018
    • April 2018
    • February 2018
    • January 2018
    • December 2017
    • November 2017
    • July 2017
    • June 2017
    • April 2017
    • March 2017
    • January 2017
    • October 2016
    • June 2016
    • May 2016
    • March 2016
    • January 2016
    • December 2015
    • July 2015
    • June 2015
    • May 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • September 2014
    • August 2014
    • July 2014
    • June 2014
    • February 2014
    • January 2014
    • December 2013
    • October 2013
    • September 2013
    • August 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • March 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • August 2012
    • July 2012
    • June 2012
    • May 2012
    • April 2012
    • March 2012
    • February 2012
    • January 2012
    • November 2011
    • October 2011
    • September 2011
    • August 2011
    • July 2011
    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • September 2010
    • August 2010
  • Follow me on Twitter

    My Tweets
  • Cloud

    American Civil War antithrombin III banana Biological imaging biotechnology Brexit Choanoflagellates chocolate chondroitin sulfate coagulation Confederate States covid19 DN Lee Education EU EU referendum Europe extracellular matrix FGF Fibroblast growth factor Food FRET sensors Gish Gallop glycosaminoglycans GMO government Graduate students heparan sulfate heparin history of science imaging Irvine Stephens Bulloch James Bulloch James Dunwoody Bulloch Liverpool microbiology Nanoparticle Nanoparticles Nanotechnology neuroscience nmr Open Access Open Data orange Parliament Peer Review PhD polysaccharide port sunlight Post publication peer review protein chemistry REF research Research Excellence Framework Research integrity Roast SARS-CoV-2 science Science and Technology Committee Science fraud Science Funding Science progress Scientific American Seminars sorbet speaking strawberry sulfation Sulfotransferase synthetic biology Teaching technology transfer Tourism Travel Universities

Blog at WordPress.com.

WPThemes.


Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Follow Following
    • Ferniglab Blog
    • Join 73 other followers
    • Already have a WordPress.com account? Log in now.
    • Ferniglab Blog
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d bloggers like this: